Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,576 | -2,415 | -5,121 | -1,582 |
| Depreciation Amortization | 276 | 174 | 483 | 0 |
| Accounts receivable | N/A | -275 | N/A | N/A |
| Other Working Capital | -329 | -258 | 307 | 172 |
| Other Operating Activity | 968 | 738 | 265 | 0 |
| Operating Cash Flow | $-3,661 | $-2,036 | $-4,066 | $-1,410 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -80 | -56 | 0 | 0 |
| Investing Cash Flow | $-80 | $-56 | $0 | $0 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | 10,000 | N/A | N/A |
| Other Financing Activity | 12,853 | 4,566 | 5,925 | 1,817 |
| Financing Cash Flow | $12,853 | $14,566 | $5,925 | $1,817 |
| Beginning Cash Position | 2,266 | 2,266 | 407 | 0 |
| End Cash Position | 11,378 | 14,740 | 2,266 | 407 |
| Net Cash Flow | $9,112 | $12,474 | $1,859 | $407 |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,661 | -2,036 | -4,066 | -1,410 |
| Capital Expenditure | -80 | -56 | N/A | N/A |
| Free Cash Flow | -3,741 | -2,092 | -4,066 | -1,410 |